| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2965788 | Journal of Cardiovascular Echography | 2011 | 5 Pages |
Abstract
As the number of drugs and therapeutic strategies for the treatment of cancer continuously increase, early detection and treatment of cardiotoxic side effects are actual and important issue. Along with left ventricular dysfunction, arrhythmic side effects are fairly common. In particular, oncologic patients often present with QT prolongation, since their conditions are associated with concomitant risk factors, such as electrolytic alterations due to dehydration, vomiting or diarrhea, pre-existing cardiovascular diseases, renal or hepathic dysfunctions, other medications which are known for predisposing to QT prolongation.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Maria Cristina Lombari, Carlo Gabriele Tocchetti, Carmela Coppola, Angelo Sabato Boccia, Nicola Maurea,